[HTML][HTML] Imatinib in advanced chordoma: a retrospective case series analysis
Introduction Imatinib showed activity in 50 chordoma patients treated within a Phase II study.
In that study, 70% of patients remained with stable disease (SD), median progression free …
In that study, 70% of patients remained with stable disease (SD), median progression free …
[引用][C] Imatinib in advanced chordoma: A retrospective case series analysis
N Hindi, PG Casali, C Morosi, A Messina… - European Journal of …, 2015 - cir.nii.ac.jp
Imatinib in advanced chordoma: A retrospective case series analysis | CiNii Research CiNii
国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
Imatinib in advanced chordoma: A retrospective case series analysis
N Hindi, PG Casali, C Morosi… - … journal of cancer …, 2015 - pubmed.ncbi.nlm.nih.gov
Introduction Imatinib showed activity in 50 chordoma patients treated within a Phase II study.
In that study, 70% of patients remained with stable disease (SD), median progression free …
In that study, 70% of patients remained with stable disease (SD), median progression free …
Imatinib in advanced chordoma: A retrospective case series analysis
N Hindi, PG Casali, C Morosi, A Messina… - European Journal of …, 2015 - ejcancer.com
Introduction Imatinib showed activity in 50 chordoma patients treated within a Phase II study.
In that study, 70% of patients remained with stable disease (SD), median progression free …
In that study, 70% of patients remained with stable disease (SD), median progression free …
Imatinib in advanced chordoma: a retrospective case series analysis
N Hindi, PG Casali, C Morosi, A Messina… - EUROPEAN JOURNAL …, 2015 - air.unimi.it
Introduction Imatinib showed activity in 50 chordoma patients treated within a Phase II study.
In that study, 70% of patients remained with stable disease (SD), median progression free …
In that study, 70% of patients remained with stable disease (SD), median progression free …
Imatinib in advanced chordoma: A retrospective case series analysis
N Hindi, PG Casali, C Morosi, A Messina… - European Journal of …, 2015 - infona.pl
Imatinib showed activity in 50 chordoma patients treated within a Phase II study. In that
study, 70% of patients remained with stable disease (SD), median progression free survival …
study, 70% of patients remained with stable disease (SD), median progression free survival …
Imatinib in advanced chordoma: A retrospective case series analysis.
N Hindi, PG Casali, C Morosi, A Messina… - European Journal of …, 2015 - europepmc.org
Methods 48 patients were consecutively treated with imatinib 800 mg/d. All patients had
inoperable and progressive disease before starting imatinib. Demographics, treatment …
inoperable and progressive disease before starting imatinib. Demographics, treatment …